MEDIDATA SOLUTIONS, INC.

Medidata Solutions, Inc. specializes in delivering clinical data management and digital trial solutions for federal health research programs, primarily through its RAVE electronic data capture (EDC) platform and integrated ancillary tools such as TSDV, EPRO, and Balance. The company provides end-to-end hosting, maintenance, and professional services for cloud-based clinical trial systems, including remote source review, study build support, post-go-live operational assistance, and training for regulatory-compliant data collection. Their technical expertise centers on secure, scalable SaaS platforms designed for FDA-regulated environments, with deep proficiency in data integrity, audit trails, and 21 CFR Part 11 compliance. Medidata’s differentiation lies in its domain-specific focus on clinical research infrastructure, enabling seamless integration of real-time monitoring, randomization, and electronic patient-reported outcomes within complex government-funded studies. The contractor maintains a sustained, high-volume relationship with the Department of Health and Human Services, delivering critical IT services to divisions including the National Cancer Institute’s Center for Biomedical Informatics and Information Technology and the Cancer Therapy Evaluation Program. Work consistently supports cancer research, clinical trial modernization, and data standardization initiatives, indicating a trusted, long-term partnership rooted in regulatory and operational reliability. Medidata operates primarily under NAICS 518210 (computing infrastructure and data processing services) and 513210 (software publishers), reflecting its dual role as both a platform provider and managed services operator for clinical trial technology. The firm is positioned as a niche enabler in the federal life sciences market, serving agencies that require secure, compliant, and scalable systems for managing sensitive human subject data. As a New York-based entity with a 2L structure and no government certifications, Medidata competes on technical credibility and proven performance within the federal health research ecosystem, rather than through socioeconomic designations. Its geographic footprint is centered in federal healthcare IT hubs, with no indication of international or commercial market diversification in its award history.